Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren regimen in hypertensive patients with renal dysfunction
jRCT2080220235Phase 3
- Sponsor
- Novartis
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aliskiren in hypertension (HTN) and chronic kidney disease (CKD), sponsored by Novartis.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080220235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220235.